TABLE 1.
Characteristics of the patient groups studieda
| Characteristic | PPI-treated (n = 12) | Untreated (n = 12) |
|---|---|---|
| Age (mean ± SD) (yr) | 56 ± 16.6 | 44.7 ± 9.6 |
| Gender (men/women) | 3/9 | 4/8 |
| Body mass index (mean ± SD) (kg/m2) | 23.0 ± 1.5 | 22.0 ± 1.8 |
| Helicobacter pylori status (positive/negative) | 4/8 | 5/7 |
| Gastric mucosa inflammation degree (mild/moderate) | 4/8 | 6/5 |
| PPI treatment before upper endoscopy (mean ± SD) (mo) | 16 ± 3 |
a
None of the comparisons were significantly different (P > 0.05, for all comparisons). Only one of the patients on proton-pump inhibitor (PPI) therapy had histological findings showing severe gastric inflammation.